A Bayesian meta-analysis of 54 studies and more than 6.8 million cataract surgeries found antibiotic injection was associated with an approximately 79% reduction in the odds of postoperative ...

Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.

X-Cel Specialty Contacts and Essilor Custom Contacts have launched Lunara, an FDA PMA-approved overnight orthokeratology lens made from 180 Dk Optimum Infinite material Lunara uses familiar tangential ...

The FDA granted De Novo marketing authorization to Avulux, establishing a new device classification for precision optical filters intended to decrease the impact of light sensitivity in patients with ...

Key Takeaways FDA approval of Ciliatech’s IDE allows the company to begin a US feasibility study of the Intercil Uveal Spacer in approxima ...

Key Takeaways Johnson & Johnson will host and participate in peer-to-peer educational programs at ESCRS 2026 covering ...

Key Takeaways Orbis' first Flying Eye Hospital simulation project in Macau will train 70 ophthalmologists and nurses from ...

Hoya Vision Care and Nidek have renewed their global strategic partnership, extending a collaboration first established in 2023 with a new agreement that will automatically renew on a yearly basis.

https://eyewire.news/news/study-finds-glp-1-drugs-linked-to-lower-risk-of-legal-blindness-in-type-2-diabetes A large real-world study suggests that widely used GLP-1 ...

Science Corporation has commercially launched the PRIMA retinal implant in Europe after receiving CE mark approval, enabling availability across 30 European countries Clinical trial results published ...

Lupin and Tenpoint Therapeutics have entered into a partnership, providing VISUfarma exclusive rights to commercialize Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% in ...